(S)-4-苄基-3-((3R,4S)-1-苄基-4-苯基吡咯烷-3-羰基)恶唑烷-2-酮 | 221141-86-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: (S)-4-苄基-3-((3R,4S)-1-苄基-4-苯基吡咯烷-3-羰基)恶唑烷-2-酮
• 英文名称: (S)-4-Benzyl-3-((3R,4S)-1-benzyl-4-phenyl-pyrrolidine-3-carbonyl)-oxazolidin-2-one
• 英文别名: 3-(1-Benzyl4-(s)-phenylpyrrolidine-3-(r)-carbonyl)-4(s)-benzyl oxazolidin-2-one；(4S)-4-benzyl-3-[(3R,4S)-1-benzyl-4-phenylpyrrolidine-3-carbonyl]-1,3-oxazolidin-2-one
• CAS: 221141-86-2
• 化学式: C₂₈H₂₈N₂O₃
• 分子量: 440.542
• InChiKey: OWVGXQSVQZOAFW-NXCFDTQHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  33
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  49.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (S)-4-苄基-3-((3R,4S)-1-苄基-4-苯基吡咯烷-3-羰基)恶唑烷-2-酮 在 palladium dihydroxide lithium aluminium tetrahydride 、 碳酸氢铵 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 生成 (3R,4S)-3-(([tert-butyl(dimethyl)silyl]oxy)methyl)-4-phenylpyrrolidine
  参考文献：
  名称：

  1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

  摘要：

  A series of 1,3,4-trisubstituted pyrrolidines was discovered to have the ability to displace [I-125]-MIP-1 alpha from the CCR5 receptor expressed on Chinese hamster ovary (CHO) cell membranes. CCR5 activity was found to be dependent on the regiochemistry and the absolute stereochemistry of the pyrrolidine. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00232-3
• 作为产物：
  描述：

  (4S)-4-benzyl-3-[(2E)-3-phenylprop-2-enoyl]-1,3-oxazolidin-2-one 、 N-(甲氧甲基)-N-(三甲基硅甲基)苄胺 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 (S)-4-苄基-3-((3R,4S)-1-苄基-4-苯基吡咯烷-3-羰基)恶唑烷-2-酮 、 (S)-4-Benzyl-3-((3S,4R)-1-benzyl-4-phenyl-pyrrolidine-3-carbonyl)-oxazolidin-2-one
  参考文献：
  名称：

  1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

  摘要：

  A series of 1,3,4-trisubstituted pyrrolidines was discovered to have the ability to displace [I-125]-MIP-1 alpha from the CCR5 receptor expressed on Chinese hamster ovary (CHO) cell membranes. CCR5 activity was found to be dependent on the regiochemistry and the absolute stereochemistry of the pyrrolidine. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00232-3

文献信息

• Pyrrolidine modulators of CCR5 chemokine receptor activity
  申请人：——

  公开号：US20020094989A1

  公开（公告）日：2002-07-18

  Pyrrolidine compounds of Formula I: 1 (wherein 1 , R 2 , R 3 , R 4 , R 5 ,R 6a , R 6b , R 7 and R 8 are defined herein) are described. The compounds are modulators of CCR5 chemokine receptor activity. The compounds are useful, for example, in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

  Pyrrolidine化合物的化学式I： 1 （其中 1 ，R 2 ，R 3 ，R 4 ，R 5 ，R 6a ，R 6b ，R 7 和R 8 在此定义）已被描述。这些化合物是CCR5趋化因子受体活性的调节剂。这些化合物可用于预防或治疗HIV感染和治疗艾滋病，作为化合物或药学上可接受的盐，或作为药物组成部分，可选择与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。还描述了治疗艾滋病的方法以及预防或治疗HIV感染的方法。
• Pyrrolidine modulators of ccr5 chemokine receptor activity
  申请人：——

  公开号：US20040087552A1

  公开（公告）日：2004-05-06

  Pyrrolidine compounds of Formula (I), (wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 6b , R 7 and R 8 are defined herein) are described. The compounds are modulators of CCR5 chemokine receptor activity. The compounds are useful, for example, in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. 1

  本文描述了化合物公式(I)的吡咯烷衍生物（其中R1、R2、R3、R4、R5、R6a、R6b、R7和R8在此定义）。这些化合物是CCR5趋化因子受体活性的调节剂。这些化合物可作为化合物或药学上可接受的盐，或作为药物组成部分，可选地与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用，例如用于预防或治疗HIV感染和治疗艾滋病。本文还描述了治疗艾滋病的方法和预防或治疗HIV感染的方法。
• [EN] PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY<br/>[FR] MODULATEURS DE PYRROLIDINE DE L'ACTIVITE DU RECEPTEUR DES CHIMIOKINES
  申请人：MERCK & CO INC

  公开号：WO2000059498A1

  公开（公告）日：2000-10-12

  The present invention is directed to pyrrolidine compounds of the formula (I) (wherein R?1, R2, R3, R4, R5, R6¿ and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.

  本发明涉及公式（I）的吡咯烷化合物（其中R1、R2、R3、R4、R5、R6和n在此定义），其作为趋化因子受体活性调节剂是有用的。特别地，这些化合物是作为趋化因子受体CCR-5和/或CCR-3的调节剂是有用的。
• [EN] PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY<br/>[FR] PYRROLIDINES MODULATEURS DE L'ACTIVITE DU RECEPTEUR DE CHIMIOKINE
  申请人：MERCK & CO INC

  公开号：WO2000059502A1

  公开（公告）日：2000-10-12

  The present invention is directed to pyrrolidine compounds of formula (I) (wherein R?1, R2, R3, R4, R5, R6, R14¿ and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.

  本发明涉及式(I)的吡咯烷化合物（其中R1，R2，R3，R4，R5，R6，R14和n在此定义），其作为趋化因子受体活性调节剂具有用途。特别地，这些化合物作为趋化因子受体CCR-5和/或CCR-3的调节剂具有用途。
• Pyrrolidine modulators of chemokine receptor activity
  申请人：Merck & Co., Inc.

  公开号：US06399619B1

  公开（公告）日：2002-06-04

  The present invention is directed to pyrrolidine compounds of the formula I: (wherein R1, R2, R3, R4, R5, R6 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.

  本发明涉及公式I的吡咯烷化合物：（其中R1，R2，R3，R4，R5，R6和n在此定义），该化合物可用作趋化因子受体活性的调节剂。特别地，这些化合物可用作趋化因子受体CCR-5和/或CCR-3的调节剂。